文献速递心脏核医学放射性药物与辐射防护

心肌灌注显像辐射剂量降低的驱动因素:大型健康系统经验

Drivers of radiation dose reduction with myocardial perfusion imaging: A large health system experience.
PubMed 文献 · J Nucl Cardiol · 2019-01-31

本研究在单一健康系统内纳入2010年1月至2016年12月的55,930例心肌灌注显像(MPI)检查,比较具备基础与高级辐射节约实践(RSP)的站点在匹配年龄、性别和体重后的平均有效剂量(E)。结果显示高级RSP组平均E显著低于基础RSP组(7±5.6 mSv vs 16±5.4 mSv,P<0.001),且达到E<9 mSv的可能性更高(65.7% vs 10.8%,OR 15.8 [95%CI 14–17.8],P<0.0001)。剂量降低的主要驱动因素为负荷-only(SO)结合固态探测器(SSD)SPECT、SO-SPECT联合高级后处理软件(APPS)、PET以及消除铊协议。

要点

  • 高级RSP使平均有效剂量从16 mSv降至7 mSv,E<9 mSv比例从10.8%升至65.7%。
  • SO-SSD SPECT是剂量降低的最大驱动因素,平均减少11.5 mSv。
  • 消除铊协议、使用PET和SO-SPECT+APPS也分别显著降低剂量。

核心结论

  • 在大健康系统中实施辐射节约实践,负荷-only协议联合现代SPECT技术、PET及消除铊协议与最大辐射剂量降低相关。

研究设计与样本

  • 回顾性队列研究,纳入2010年1月至2016年12月单一健康系统内55,930例MPI检查,按年龄、性别和体重匹配患者,比较基础与高级RSP站点的平均有效剂量。

主要发现

  • 高级RSP组平均E为7±5.6 mSv,基础RSP组为16±5.4 mSv(P<0.001)。
  • 高级RSP组达到E<9 mSv的比例为65.7%,基础RSP组为10.8%(OR 15.8 [95%CI 14–17.8],P<0.0001)。
  • SO-SSD SPECT平均降低剂量11.5 mSv,SO-SPECT+APPS降低10.1 mSv,PET降低9.7 mSv,消除铊协议降低9.1 mSv(所有比较P<0.0001)。

关键数值与推荐

  • 基础RSP定义为消除铊基协议并在常规SPECT相机上使用负荷-only成像。
  • 高级RSP定义为额外使用固态探测器SPECT相机、高级后处理软件或PET成像。
  • 辐射剂量目标为E<9 mSv。

临床怎么用

  • 在核医学实验室推广负荷-only协议联合现代SPECT技术、PET及消除铊协议,可显著降低MPI有效剂量并提高达标率。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increasing emphasis on reducing radiation exposure from myocardial perfusion imaging (MPI), the use of radiation-sparing practices (RSP) at nuclear laboratories remains limited. Defining real-world impact of RSPs on effective radiation dose (E) can potentially further motivate their adoption. METHODS: MPI studies performed between 1/2010 and 12/2016 within a single health system were included. Mean E was compared between sites with 'basic' RSP (defined as elimination of thallium-based protocols and use of stress-only (SO) imaging on conventional single photon emission computed tomography (SPECT) cameras) and those with 'advanced' capabilities (sites that additionally used solid-state detector (SSD) SPECT cameras, advanced post-processing software (APPS) or positron emission tomography (PET) imaging), after matching patients by age, gender, and weight. Contributions of individual RSP to E reduction were determined using multiple linear regression after adjusting for factors affecting tracer dose. RESULTS: Among 55,930 MPI studies performed, the use of advanced RSP was associated with significantly lower mean E compared to basic RSP (7 ± 5.6 mSv and 16 ± 5.4 mSv, respectively; P < 0.001), with a greater likelihood of achieving E < 9 mSv (65.7% vs. 10.8%, respectively; OR 15.8 [95% CI 14 to 17.8]; P < 0.0001). Main driver of E reduction was SO-SSD SPECT (mean reduction = 11.5 mSv), followed by use of SO-SPECT + APPS (mean reduction = 10.1 mSv), ;ET (mean reduction = 9.7 mSv); and elimination of thallium protocols (mean reduction = 9.1 mSv); P < 0.0001 for all comparisons. CONCLUSION: In a natural experiment with implementation of radiation-saving practices at a large health system, stress-only protocols used in conjunction with modern SPECT technologies, the use of PET and elimination of thallium-based protocols were associated with greatest reductions in radiation dose. Availability of several approaches to dose reduction within a health system can facilitate achievement of targeted radiation benchmarks in a greater number of performed studies.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Al Badarin FJ, Spertus JA, Bateman TM, et al. Drivers of radiation dose reduction with myocardial perfusion imaging: A large health system experience. J Nucl Cardiol. 2019. PMID: 30706351. doi:10.1007/s12350-018-01576-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。